세계의 생식 유전학 시장 : 제품 유형별, 시술 유형별, 기술별, 용도별, 지역별(2025-2033년)

The global reproductive genetics market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 59.8 Billion by 2033, exhibiting a growth rate (CAGR) of 25.13% during 2025-2033. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Type Insights:

• Kits
• Laboratory Developed Tests (LDT)
• Reagents and Consumables

Procedure Type Insights:

• Carrier Screening
• Pre-Natal Screening
• Pre-Implantation Genetic Testing
• Infertility Genetic Testing

Technology Insights:

• Next-Generation Sequencing
• Polymerase Chain Reaction
• In Situ Hybridization (ISH/FISH)
• Microarray

Application Insights:

• Aneuploidy
• Structural Chromosomal Abnormality
• Single Gene Disorder
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global reproductive genetics market?
• What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
• What are the key regional markets?
• Which countries represent the most attractive reproductive genetics market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the reproductive genetics market?
• What is the breakup of the market based on the procedure type?
• Which is the most attractive procedure type in the reproductive genetics market?
• What is the breakup of the market based on the technology?
• Which is the most attractive technology in the reproductive genetics market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the reproductive genetics market?
• What is the competitive structure of the global reproductive genetics market?
• Who are the key players/companies in the global reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Kits
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Laboratory Developed Tests (LDT)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Reagents and Consumables
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

• 7.1 Carrier Screening
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Pre-Natal Screening
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Pre-Implantation Genetic Testing
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Infertility Genetic Testing
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Technology

• 8.1 Next-Generation Sequencing
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Polymerase Chain Reaction
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 In Situ Hybridization (ISH/FISH)
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Microarray
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Application

• 9.1 Aneuploidy
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Structural Chromosomal Abnormality
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Single Gene Disorder
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

• 11.1 Overview
• 11.2 Drivers
• 11.3 Restraints
• 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Bangkok Genomics Innovation Public Company Limited
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Centogene N.V.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Fulgent Genetics Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Igenomix (Vitrolife Group)
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Invitae Corporation
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Laboratory Corporation of America Holdings
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 PerkinElmer Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Thermo Fisher Scientific Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.